IDP.L

InnovaDerma Plc
InnovaDerma PLC - Director/PDMR Shareholding
24th December 2021, 12:41
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8006W
InnovaDerma PLC
24 December 2021
 

InnovaDerma PLC

("InnovaDerma" or the "Company")

Director/PDMR shareholding

 

InnovaDerma (LSE: IDP), a leading digitally focused UK beauty brand developer, announces that it was notified on 24 December 2021, Mark Ward, Non-executive Director has purchased 376,799 Ordinary Shares of €0.10 each in the Company at an average price of 35.0 pence per Ordinary Share.

Following the purchase, Mark Ward now holds a total of 5,049,076 Ordinary Shares representing approximately 18.44% of the issued share capital of the Company.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Further enquiries  

InnovaDerma  

Blake Hughes 

 

 

c/o TB Cardew 

 

finnCap Ltd  

Geoff Nash/Kate Bannatyne 

Alice Lane - Corporate Broking 

 

+44 (0)207 220 0500 

www.finncap.com 

TB Cardew  

Shan Shan Willenbrock/ 

Olivia Rosser 

 

+ 44 (0)7775 848537 

+ 44 (0)20 7930 0777 

innovaDerma@tbcardew.com  

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Ward

2. 

Reason for the Notification

 

a)

Position/status

Non-executive Director

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

InnovaDerma PLC

 

b)

LEI

213800WRAP6W8VDL6B38

 

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the Financial instrument, type of instrument

€0.10 each ("Ordinary Shares")

Identification code

IDP   GB00BT9PTW34

 

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

Volume - 376,799 Ordinary Shares

Average Price - 35 pence per Ordinary Share

 

d)

Aggregated information:

Aggregated volume

Price

 

See 4c) above

 

e)

Date of the transaction

23 December 2021

 

f)

Place of the transaction

London Stock Exchange, Main Market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUSOURAKUUUAA ]]>
TwitterFacebookLinkedIn